182 related articles for article (PubMed ID: 33863912)
41. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection.
Sekine Y; Yamada Y; Chiyo M; Iwata T; Nakajima T; Yasufuku K; Suzuki M; Fujisawa T
Ann Thorac Surg; 2007 Sep; 84(3):946-50. PubMed ID: 17720404
[TBL] [Abstract][Full Text] [Related]
42. Measures of bronchodilator response of FEV
Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
[TBL] [Abstract][Full Text] [Related]
43. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.
Palma D; Lagerwaard F; Rodrigues G; Haasbeek C; Senan S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1149-56. PubMed ID: 21640513
[TBL] [Abstract][Full Text] [Related]
44. The impact of heart failure on the classification of COPD severity.
Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
[TBL] [Abstract][Full Text] [Related]
45. Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.
Nojiri T; Inoue M; Yamamoto K; Maeda H; Takeuchi Y; Nakagiri T; Shintani Y; Minami M; Sawabata N; Okumura M
Surg Today; 2014 Feb; 44(2):285-90. PubMed ID: 23307265
[TBL] [Abstract][Full Text] [Related]
46. Fast-track pulmonary conditioning before urgent cardiac surgery in patients with insufficiently treated chronic obstructive pulmonary disease.
Dreger H; Schaumann B; Gromann T; Hetzer R; Melzer C
J Cardiovasc Surg (Torino); 2011 Aug; 52(4):587-91. PubMed ID: 21499224
[TBL] [Abstract][Full Text] [Related]
47. Perioperative rehabilitation and physiotherapy for lung cancer patients with chronic obstructive pulmonary disease.
Sekine Y; Chiyo M; Iwata T; Yasufuku K; Furukawa S; Amada Y; Iyoda A; Shibuya K; Iizasa T; Fujisawa T
Jpn J Thorac Cardiovasc Surg; 2005 May; 53(5):237-43. PubMed ID: 15952314
[TBL] [Abstract][Full Text] [Related]
48. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
[TBL] [Abstract][Full Text] [Related]
49. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
Zheng J; Baldi S; Zhao L; Li H; Lee KH; Singh D; Papi A; Grapin F; Guasconi A; Georges G
Respir Res; 2021 Mar; 22(1):90. PubMed ID: 33757520
[TBL] [Abstract][Full Text] [Related]
51. Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair
Yildiz P; Bayraktaroglu M; Gorgun D; Secik F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2859-2867. PubMed ID: 27920513
[TBL] [Abstract][Full Text] [Related]
52. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
[TBL] [Abstract][Full Text] [Related]
53. An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD.
Singh D; D'Urzo AD; Donohue JF; Kerwin EM; Molins E; Chuecos F; Ribera A; Jarreta D
Int J Chron Obstruct Pulmon Dis; 2019; 14():2835-2848. PubMed ID: 31827323
[TBL] [Abstract][Full Text] [Related]
54. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
Quinn D; Barnes CN; Yates W; Bourdet DL; Moran EJ; Potgieter P; Nicholls A; Haumann B; Singh D
Pulm Pharmacol Ther; 2018 Feb; 48():71-79. PubMed ID: 28987804
[TBL] [Abstract][Full Text] [Related]
55. Six-minute walking and pulmonary function test outcomes during the early period after lung cancer surgery with special reference to patients with chronic obstructive pulmonary disease.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K
Jpn J Thorac Cardiovasc Surg; 2004 Mar; 52(3):113-9. PubMed ID: 15077844
[TBL] [Abstract][Full Text] [Related]
56. Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease.
Takegahara K; Usuda J; Inoue T; Ibi T; Sato A
Gen Thorac Cardiovasc Surg; 2017 Jul; 65(7):388-391. PubMed ID: 28281043
[TBL] [Abstract][Full Text] [Related]
57. Comparison of pre- and post-bronchodilator lung function as predictors of mortality: The HUNT Study.
Bhatta L; Leivseth L; Carslake D; Langhammer A; Mai XM; Chen Y; Henriksen AH; Brumpton BM
Respirology; 2020 Apr; 25(4):401-409. PubMed ID: 31339206
[TBL] [Abstract][Full Text] [Related]
58. [A three years longitudinal follow-up study of pulmonary function changes in patients with chronic obstructive pulmonary disease].
Wang J; Zhou XM; Yang X; Zhao ST; Ma QL; Wang CZ
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):302-6. PubMed ID: 27030620
[TBL] [Abstract][Full Text] [Related]
59. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
Marin JM; Beeh KM; Clemens A; Castellani W; Schaper L; Saralaya D; Gunstone A; Casamor R; Kostikas K; Aalamian-Mattheis M
Int J Chron Obstruct Pulmon Dis; 2016; 11():1425-34. PubMed ID: 27418815
[TBL] [Abstract][Full Text] [Related]
60. Regional lung response to bronchodilator reversibility testing determined by electrical impedance tomography in chronic obstructive pulmonary disease.
Vogt B; Zhao Z; Zabel P; Weiler N; Frerichs I
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L8-L19. PubMed ID: 27190067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]